Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1973 1
1975 1
1979 1
1980 2
1982 2
1983 1
1984 1
1985 3
1986 2
1987 2
1988 2
1989 3
1992 2
1993 5
1994 5
1995 4
1996 3
1997 5
1998 3
1999 8
2000 3
2001 6
2002 3
2003 6
2004 9
2005 11
2006 10
2007 12
2008 9
2009 13
2010 12
2011 10
2012 18
2013 30
2014 57
2015 52
2016 58
2017 76
2018 114
2019 99
2020 125
2021 125
2022 94
2023 106
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

1,039 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.
Simmons D, Immanuel J, Hague WM, Teede H, Nolan CJ, Peek MJ, Flack JR, McLean M, Wong V, Hibbert E, Kautzky-Willer A, Harreiter J, Backman H, Gianatti E, Sweeting A, Mohan V, Enticott J, Cheung NW; TOBOGM Research Group. Simmons D, et al. N Engl J Med. 2023 Jun 8;388(23):2132-2144. doi: 10.1056/NEJMoa2214956. Epub 2023 May 5. N Engl J Med. 2023. PMID: 37144983 Clinical Trial.
IMI Pathologic Myopia.
Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatorn K, Fang Y, Cheung CMG, Lai TYY, Ikuno Y, Cohen SY, Gaudric A, Jonas JB. Ohno-Matsui K, et al. Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):5. doi: 10.1167/iovs.62.5.5. Invest Ophthalmol Vis Sci. 2021. PMID: 33909033 Free PMC article. Review.
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. Perkins RB, et al. J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. J Low Genit Tract Dis. 2020. PMID: 32243307 Free PMC article. No abstract available.
Pachychoroid disease.
Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Cheung CMG, et al. Eye (Lond). 2019 Jan;33(1):14-33. doi: 10.1038/s41433-018-0158-4. Epub 2018 Jul 11. Eye (Lond). 2019. PMID: 29995841 Free PMC article. Review.
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Clinical Trial.
At 12 months, the least-squares mean (SE) change from baseline in eGFR was -2.71.8, 0.21.7, -1.51.8, and -7.41.8 ml per minute per 1.73 m(2) in the sibeprenlimab 2-mg, 4-mg, and 8-mg groups and the placebo group, respectively. ...
At 12 months, the least-squares mean (SE) change from baseline in eGFR was -2.71.8, 0.21.7, -1.51.8, and -7.41.8 ml per minute per 1.73 m …
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.
Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, Balasubramanian V, Russo AM, Rajmane A, Cheung L, Hung G, Lee J, Kowey P, Talati N, Nag D, Gummidipundi SE, Beatty A, Hills MT, Desai S, Granger CB, Desai M, Turakhia MP; Apple Heart Study Investigators. Perez MV, et al. N Engl J Med. 2019 Nov 14;381(20):1909-1917. doi: 10.1056/NEJMoa1901183. N Engl J Med. 2019. PMID: 31722151 Free PMC article. Clinical Trial.
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac MC, Dakin LA, Friedman DJ, Bramham K, Campbell K, Knebelmann B, Barisoni L, Falk RJ, Gipson DS, Lipkowitz MS, Ojo A, Bunnage ME, Pollak MR, Altshuler D, Chertow GM; VX19-147-101 Study Group. Egbuna O, et al. N Engl J Med. 2023 Mar 16;388(11):969-979. doi: 10.1056/NEJMoa2202396. N Engl J Med. 2023. PMID: 36920755 Clinical Trial.
We then conducted a single-group, open-label, phase 2a clinical study in which inaxaplin was administered to participants who had two APOL1 variants, biopsy-proven focal segmental glomerulosclerosis, and proteinuria (urinary protein-to-creatinine ratio of 0.7 to <10 [with prot …
We then conducted a single-group, open-label, phase 2a clinical study in which inaxaplin was administered to participants who had two APOL1 …
NSUN2-Mediated m(5)C Methylation Impairs Endometrial Receptivity.
Lu J, Zhang M, Liu Z, Guo L, Huang P, Xia W, Li J, Lv J, Cheung HH, Ding C, Li H, Huang B. Lu J, et al. Lab Invest. 2024 Apr;104(4):100327. doi: 10.1016/j.labinv.2024.100327. Epub 2024 Jan 17. Lab Invest. 2024. PMID: 38237738
The overall pattern of m(5)C sites and genes was elucidated through m(5)C-BS-seq, whereas the overall m(5)C levels in different groups were revealed by dot blot assay. ...Our results uncovered a novel intricate regulatory mechanism betwee …
The overall pattern of m(5)C sites and genes was elucidated through m(5)C-BS-seq, whereas the overall m(5 …
1,039 results